From the Department of Orthopaedic Surgery, Stanford University, Stanford, CA (Dr. Chou, Dr. Pun, Dr. Ladd); Walter Reed National Military Medical Center, Bethesda, MD (Dr. Johnson); the Department of Orthopaedic Surgery, University of California - San Francisco San Francisco, CA (Dr. Shapiro); Novant Health Orthopaedic Fracture Clinic, Charlotte, NC (Dr. Cannada); the Department of Orthopaedic Surgery, Harvard Medical School Boston, MA (Dr. Chen); the Department of Orthopaedic Surgery, California Pacific Orthopaedics San Fransciso, CA (Dr. Valone); the Department of Orthopaedic Surgery, Medical University of South Carolina Charleston, SC (Dr. Van Nortwick); and the Department of Orthopaedic Surgery, Palo Alto Veterens Association Palo Alto, CA (Dr. Finlay).
J Am Acad Orthop Surg Glob Res Rev. 2022 May 1;6(5):e22.00031. doi: 10.5435/JAAOSGlobal-D-22-00031.
Cancer is the second leading cause of death among women in the United States. Previous studies demonstrate a higher prevalence of cancer among female orthopaedic surgeons. This study aimed to provide an updated prevalence of breast and all-cause cancer among female orthopaedic surgeons using a larger and more current study population.
We distributed surveys to female orthopaedic surgeons in national orthopaedic specialty societies. Six hundred seventy-two survey responses were collected. We calculated standardized prevalence ratios (SPRs) and 95% confidence intervals (CIs) based on gender-specific, race-specific, and age-specific cancer prevalence statistics in the US population. We compared the distribution of breast cancer risk factors with that of women in the 2018 and 2009 California Health Interview Survey.
Fifty-one of the 672 surveyed surgeons reported a diagnosis of invasive cancer. Twenty reported breast cancer with a prevalence higher among female orthopaedic surgeons compared with the US female population (SPR: 2.89, 95% CI: 2.16 to 3.81, P < 0.001). The breast cancer prevalence was also higher among orthopaedic surgeons compared with the US female population (SPR: 3.97, 95% CI: 2.43 to 6.14, P = 0.003).
The increased prevalence of breast and all-cause cancer among a larger and more diverse cohort of female orthopaedic surgeons confirms previous studies and provides an update regarding a concerning public health issue within this specialty.
癌症是美国女性死亡的第二大主要原因。先前的研究表明,女性骨科医生中癌症的发病率更高。本研究旨在使用更大且更当前的研究人群,提供女性骨科医生中乳腺癌和所有原因癌症的患病率的最新数据。
我们向全国骨科专业协会的女性骨科医生分发了调查。共收集到 672 份调查回复。我们根据美国人口中特定性别、特定种族和特定年龄的癌症患病率统计数据计算了标准化患病率比(SPR)和 95%置信区间(CI)。我们将乳腺癌危险因素的分布与 2018 年和 2009 年加利福尼亚健康访谈调查的女性进行了比较。
在接受调查的 672 名外科医生中,有 51 名报告了浸润性癌症的诊断。20 名报告了乳腺癌,女性骨科医生中的患病率高于美国女性人群(SPR:2.89,95%CI:2.16 至 3.81,P <0.001)。与美国女性人群相比,骨科医生中的乳腺癌患病率也更高(SPR:3.97,95%CI:2.43 至 6.14,P = 0.003)。
在更大且更多样化的女性骨科医生队列中,乳腺癌和所有原因癌症的患病率增加证实了先前的研究,并提供了有关该专业中令人关注的公共卫生问题的最新信息。